| Feb 23, 2026 |
Feb 24, 2026 |
Maynard Ryan D
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 24, 2026 |
Maynard Ryan D
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 5, 2026 |
Feb 6, 2026 |
GOTTSCHALK ADRIAN
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 30, 2026 |
Feb 2, 2026 |
Costa Carlos
|
Chief People Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 30, 2026 |
Feb 2, 2026 |
LaCascia Michael
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 30, 2026 |
Feb 2, 2026 |
Cardama Alfonso Quintas
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 30, 2026 |
Feb 2, 2026 |
Rivkin Anna
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 30, 2026 |
Feb 2, 2026 |
Bellon Steven F.
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 13, 2026 |
Jan 15, 2026 |
Flagship Pioneering, LLC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 17, 2025 |
Humer Kristian
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 17, 2025 |
SMITH IAN F
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 17, 2025 |
PARSHALL B LYNNE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 17, 2025 |
Mendelsohn Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 17, 2025 |
Lynch Thomas J. Jr.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 17, 2025 |
GILL SIMBA
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 17, 2025 |
Biller Scott
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 17, 2025 |
Jun 17, 2025 |
Cole Douglas G.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2025 |
May 2, 2025 |
Gallagher Neil
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2025 |
May 2, 2025 |
Duty Stuart
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 2, 2025 |
Gallagher Neil
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 2, 2025 |
Duty Stuart
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 25, 2025 |
Apr 28, 2025 |
GOTTSCHALK ADRIAN
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 9, 2025 |
Apr 10, 2025 |
GOTTSCHALK ADRIAN
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2025 |
Jan 24, 2025 |
Cardama Alfonso Quintas
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2025 |
Jan 24, 2025 |
Humer Kristian
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2025 |
Jan 24, 2025 |
Costa Carlos
|
Chief People Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2025 |
Jan 24, 2025 |
Rivkin Anna
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2025 |
Jan 24, 2025 |
GOTTSCHALK ADRIAN
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2025 |
Jan 24, 2025 |
Bellon Steven F.
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2025 |
Jan 24, 2025 |
LaCascia Michael
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 30, 2024 |
Koppel Adam
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 20, 2024 |
Sep 24, 2024 |
Costa Carlos
|
Chief People Officer |
Sell |
7.5
|
-36,613
|
-100.00%
|
✓
|
$367.7K |
| Sep 18, 2024 |
Sep 20, 2024 |
Costa Carlos
|
Chief People Officer |
Sell |
10.0
|
-11,574
|
-100.00%
|
✓
|
$116.3K |
| Sep 16, 2024 |
Sep 18, 2024 |
Costa Carlos
|
Chief People Officer |
Sell |
10.0
|
-10,672
|
-100.00%
|
✓
|
$107.1K |
| Sep 9, 2024 |
Sep 11, 2024 |
Bellon Steven F.
|
Chief Scientific Officer |
Sell |
20.0
|
-20,000
|
-16.40%
|
✓
|
$190K |
| Sep 3, 2024 |
Sep 4, 2024 |
Rivkin Anna
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 4, 2024 |
Rivkin Anna
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 26, 2024 |
Jun 28, 2024 |
Biller Scott
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 26, 2024 |
Jun 28, 2024 |
Mendelsohn Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 26, 2024 |
Jun 28, 2024 |
SMITH IAN F
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 26, 2024 |
Jun 28, 2024 |
Lynch Thomas J. Jr.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 26, 2024 |
Jun 28, 2024 |
GILL SIMBA
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 26, 2024 |
Jun 28, 2024 |
Cole Douglas G.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 26, 2024 |
Jun 28, 2024 |
PARSHALL B LYNNE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 26, 2024 |
Jun 28, 2024 |
Koppel Adam
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 24, 2024 |
Cavalie Fanny
|
Chief Strategy/Bus Ops Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 22, 2024 |
May 24, 2024 |
Flagship Pioneering Inc.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 24, 2024 |
Flagship Pioneering Fund VII General Partner LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 16, 2024 |
Apr 17, 2024 |
Humer Kristian
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 17, 2024 |
Humer Kristian
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 11, 2024 |
Mar 12, 2024 |
Cavalie Fanny
|
Chief Strategy/Bus Ops Officer |
Sell |
22.5
|
-11,000
|
-12.64%
|
✗
|
$72.1K |
| Jan 24, 2024 |
Jan 25, 2024 |
GOTTSCHALK ADRIAN
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 24, 2024 |
Jan 25, 2024 |
Cardama Alfonso Quintas
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 24, 2024 |
Jan 25, 2024 |
Cavalie Fanny
|
Chief Strategy/Bus Ops Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 24, 2024 |
Jan 25, 2024 |
Costa Carlos
|
Chief People Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 24, 2024 |
Jan 25, 2024 |
Bellon Steven F.
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 24, 2024 |
Jan 25, 2024 |
LaCascia Michael
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 17, 2024 |
Reine Allan
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 8, 2023 |
Dec 12, 2023 |
SMITH IAN F
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 13, 2023 |
Agresta Samuel
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 11, 2023 |
Sep 13, 2023 |
Cardama Alfonso Quintas
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 13, 2023 |
Cardama Alfonso Quintas
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 16, 2023 |
Aug 18, 2023 |
Agresta Samuel
|
Chief Medical Officer |
Sell |
17.5
|
-311,297
|
-100.00%
|
✗
|
$2.6M |
| Aug 17, 2023 |
Aug 18, 2023 |
GOTTSCHALK ADRIAN
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 21, 2023 |
Jun 22, 2023 |
PARSHALL B LYNNE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 21, 2023 |
Jun 22, 2023 |
Lynch Thomas J. Jr.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 21, 2023 |
Jun 22, 2023 |
Cole Douglas G.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 21, 2023 |
Jun 22, 2023 |
SMITH IAN F
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 21, 2023 |
Jun 22, 2023 |
Biller Scott
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 21, 2023 |
Jun 22, 2023 |
Koppel Adam
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 21, 2023 |
Jun 22, 2023 |
GILL SIMBA
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 21, 2023 |
Jun 22, 2023 |
Mendelsohn Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 26, 2023 |
May 31, 2023 |
GOTTSCHALK ADRIAN
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 10, 2022 |
Feb 22, 2023 |
GOTTSCHALK ADRIAN
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 26, 2023 |
Jan 30, 2023 |
Agresta Samuel
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 26, 2023 |
Jan 30, 2023 |
Cavalie Fanny
|
Chief Strategy/Bus Ops Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 26, 2023 |
Jan 30, 2023 |
Bellon Steven F.
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 26, 2023 |
Jan 30, 2023 |
Costa Carlos
|
Chief People Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 26, 2023 |
Jan 30, 2023 |
LaCascia Michael
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 26, 2023 |
Jan 30, 2023 |
GOTTSCHALK ADRIAN
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 26, 2023 |
Jan 30, 2023 |
Reine Allan
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 27, 2022 |
Oct 31, 2022 |
Lynch Thomas J. Jr.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 31, 2022 |
Lynch Thomas J. Jr.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 16, 2022 |
Sep 19, 2022 |
GOTTSCHALK ADRIAN
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 12, 2022 |
Sep 14, 2022 |
GILL SIMBA
|
Director |
Neutral |
27.5
|
-47,939
|
-58.46%
|
✗
|
- |
|
Sep 13, 2022 |
SMITH IAN F
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 9, 2022 |
PARSHALL B LYNNE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 9, 2022 |
Costa Carlos
|
Chief People Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 9, 2022 |
Cavalie Fanny
|
Chief Strategy/Bus Ops Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Sep 2, 2022 |
KADOCH CIGALL
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 16, 2022 |
Aug 18, 2022 |
PARSHALL B LYNNE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 18, 2022 |
PARSHALL B LYNNE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 11, 2022 |
Aug 15, 2022 |
Bellon Steven F.
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 1, 2022 |
Aug 3, 2022 |
Costa Carlos
|
Chief People Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 3, 2022 |
Costa Carlos
|
Chief People Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 21, 2022 |
Jun 22, 2022 |
Biller Scott
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 21, 2022 |
Jun 22, 2022 |
Mendelsohn Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 21, 2022 |
Jun 22, 2022 |
Cole Douglas G.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 21, 2022 |
Jun 22, 2022 |
SMITH IAN F
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 21, 2022 |
Jun 22, 2022 |
KADOCH CIGALL
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |